Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae
about
In vitro and in vivo antibacterial activities of BMY 40062, a new fluoronaphthyridoneHaemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: antimicrobial susceptibility patterns from the SENTRY antimicrobial Surveillance Program (United States and Canada, 1997)Comparison of broth microdilution method using Haemophilus test medium and agar dilution method for susceptibility testing of Eikenella corrodens.Clonal distribution of invasive Neisseria meningitidis isolates from the Norwegian county of Telemark, 1987 to 1995In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. Medical Centers in 1992 and 1993.Influence of variations in test methods on susceptibility of Haemophilus influenzae to ampicillin, azithromycin, clarithromycin, and telithromycin.Identification of beta-lactamase-negative, ampicillin-resistant strains of Haemophilus influenzae with four methods and eight mediaDiversity of beta-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae.In vitro activity of OPC-17116.In vitro activity of tosufloxacin, a new quinolone, against respiratory pathogens derived from cystic fibrosis sputum.Haemophilus influenzae: antibiotic susceptibility.Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance studyHaemophilus influenzae carriage in children attending French day care centers: a molecular epidemiological study.Isolation and characterization of a mutant of Haemophilus influenzae type b deficient in outer membrane protein P1In vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.Antibacterial activity of RU 64004 (HMR 3004), a novel ketolide derivative active against respiratory pathogensAmpicillin killing curve patterns for ampicillin-susceptible nontypeable Haemophilus influenzae strains by the agar dilution plate count method.Problems with current recommendations for susceptibility testing of Haemophilus influenzae.Comparative in vitro activity of a new quinolone, fleroxacin, against respiratory pathogens from patients with cystic fibrosis.Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United StatesIn vitro and in vivo evaluations of a new broad-spectrum oral cephalosporin, BMY-28232, and its prodrug esters.In vitro activities and targets of three cephem antibiotics against Haemophilus influenzaeIn vitro susceptibility testing of Haemophilus influenzae: review of new National Committee for Clinical Laboratory Standards recommendations.Influence of storage and susceptibility test conditions on stability and activity of LY163892 and four other cephalosporins.Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides.In vitro activity of E-1040, a 3-substituted cephalosporin, against pathogens from cystic fibrosis sputum.Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humans.Comparative in vitro activity of cefixime against Haemophilus influenzae isolates, including ampicillin-resistant, non-beta-lactamase-producing isolates, from pediatric patients.Antimicrobial susceptibility testing of Haemophilus influenzae, Branhamella catarrhalis, and Neisseria gonorrhoeae.Sulfonamide resistance in Neisseria meningitidis as defined by site-directed mutagenesis could have its origin in other species.Susceptibilities of beta-lactamase-producing and -nonproducing ampicillin-resistant strains of Haemophilus influenzae to ceftibuten, cefaclor, cefuroxime, cefixime, cefotaxime, and amoxicillin-clavulanic acid.Preincubation of Haemophilus influenzae with subinhibitory concentrations of macrolides: influence on human neutrophil chemiluminescence.Isolation of moderately penicillin-susceptible strains of Neisseria meningitidis in Argentina.In vitro activity of the new fluoroquinolone CP-99,219.In vitro activity of SCE-2787, a new cephalosporin with potent activity against Pseudomonas aeruginosa and members of the family Enterobacteriaceae.In vitro activity of sparfloxacin (AT-4140), a new quinolone agent, against invasive isolates from pediatric patientsIn vitro and in vivo intraleukocytic accumulation of azithromycin (CP-62, 993) and its influence on ex vivo leukocyte chemiluminescence.In vitro activity and susceptibility to hydrolysis of S-1006.Bactericidal titers of loracarbef (LY 163892) in serum and killing rates in volunteers receiving 400 versus 200 milligrams.In vitro activity and beta-lactamase stability of LJC 10,627
P2860
Q28359405-91AFE2AC-80CB-42DB-BAED-44C770EA077AQ30453668-D927DB71-68AA-4457-BC7A-2E74331D35C2Q33677268-D0608803-B0F5-4949-B2CE-40E008F039F8Q33682773-A0A5AB95-7266-480F-93DB-9CEC2C343BB2Q33761598-FBB3EF59-FF6F-41C0-9C13-5D2A194C4DB1Q33970783-7A2EB231-7D2D-471C-9A74-6D7141A615D2Q33982149-A6C373F1-B862-4978-BA2B-F226E90F363CQ34109916-778C4B21-CE40-4EF1-9C94-628E7E58381AQ34537966-B631D611-5079-4B96-B062-9312AA7CCCB7Q34622742-14AB20DF-A86F-4F93-A314-0E65CAF99EA1Q34685154-24C0DCB8-CB9C-40F6-8496-262426FC8937Q34737818-F01361F3-B66F-474B-8ACB-FA668B2DC352Q34974273-673B27E4-7210-4E54-8F68-0A1DE305FB8BQ35093283-3ABDFF40-B7EC-4F90-9448-4A0142C34202Q35137355-4E77FF03-C2AA-41D5-BDAB-81694AC23805Q35138464-FAE8BE57-EB43-479B-BDD9-BEF4F20E176BQ35260012-392500B4-BE37-4EAB-B6D3-C867C591CAEFQ35268189-DD71D385-F21A-4CED-B994-BCCFC381E116Q35276315-415784CF-CEB6-4E1C-96FA-FD5997EBB344Q35280150-122C5B59-BBE9-487D-AEDD-DAAE7F9F3722Q35326715-65926D4D-3579-4222-8B8D-BC1E9B62CC93Q35358847-31BA786B-D4B8-485D-98A2-FDD4AF0C3E28Q35550362-2BC56968-17A2-418E-90C5-72F18D58B30AQ35564276-3E362B22-37CF-4B22-AA06-DC298E1438ABQ35564733-1C7383E1-2C68-48EF-87D2-5C1706B273F3Q35565181-004E6CCE-B2A9-4CFD-A49E-C8243B3665BFQ35565331-0B72CC1A-B518-45CC-AD4E-B8733778BBAAQ35565470-59DFA2AD-91E3-4A44-9DCB-48760856FC3BQ35565622-D65A9536-16A7-481B-9D57-7966E1AF8D28Q35592417-9599221F-8E4B-4CF9-98EB-E53E7B43B37FQ35807412-314CB325-B45F-4ABF-AAE1-7CE40CFEFB73Q35814392-F31288AD-0EE3-436C-A3E4-5168D7BA7F0AQ35818339-93725F6E-D24B-4609-B223-3CA09D10EC1DQ35822395-CC1313E3-4CAC-47D3-8813-747828273B82Q35823389-94766300-AA4F-4E36-B3E2-BB379523845DQ35823963-0DC91276-7D70-4DAF-A096-8E78AD91F420Q35862819-BF9C00D7-CF09-4FC7-8F58-C9229BADD719Q35862953-E4AF1DB9-128E-4F0A-86A1-32A8218E025AQ35866980-307E8A7F-C94A-4C68-B19C-4ED21BCAA731Q35884855-C1DDF2EC-05E8-4395-B2F6-B867F782C3A1
P2860
Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae
@en
Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae.
@nl
type
label
Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae
@en
Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae.
@nl
prefLabel
Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae
@en
Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae.
@nl
P2093
P2860
P1476
Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae
@en
P2093
Jorgensen JH
Redding JS
P2860
P304
P407
P577
1987-11-01T00:00:00Z